Chromocell Therapeutics Corp.

As of June 20, 2025, the technical trend is mildly bearish, indicated by bearish weekly MACD and KST indicators, a bearish monthly RSI, and a lack of strong bullish signals across multiple indicators, despite some mildly bullish daily moving averages.

Chromocell Therapeutics Corp. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $2 million and a market cap of $7.52 million. Key financial metrics indicate it is not profitable, with a P/E ratio and dividend yield of 0.00%.

As of Jun 18, Chromocell Therapeutics Corp. has a market capitalization of 7.52 million, with net sales of 0.00 million and a net profit of -10.06 million over the latest four quarters. Shareholder's funds are at -6.44 million, and total assets are 0.10 million as of Dec 23.